Kozak & Associates’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.2K Sell
108
-122
-53% -$21.2K ﹤0.01% 234
2026
Q1
$44.1K Hold
230
0.01% 156
2025
Q4
$64.6K Hold
230
0.01% 129
2025
Q3
$55.5K Hold
230
0.01% 143
2025
Q2
$68.4K Hold
230
0.01% 130
2025
Q1
$66.7K Hold
230
0.02% 117
2024
Q4
$81.4K Hold
230
0.02% 108
2024
Q3
$85.6K Hold
230
0.02% 106
2024
Q2
$70.3K Hold
230
0.02% 109
2024
Q1
$70.8K Sell
230
-87
-27% -$31.7K 0.02% 113
2023
Q4
$112K Hold
317
0.04% 96
2023
Q3
$99K Hold
317
0.04% 103
2023
Q2
$98.6K Hold
317
0.04% 107
2023
Q1
$90.6K Hold
317
0.04% 116
2022
Q4
$85K Hold
317
0.04% 118
2022
Q3
$80K Hold
317
0.05% 114
2022
Q2
$88K Hold
317
0.06% 116
2022
Q1
$98K Hold
317
0.06% 115
2021
Q4
$98K Hold
317
0.06% 115
2021
Q3
$117K Buy
+317
New +$103K 0.07% 103

Other funds holding ACN

Kozak & Associates's ACN Position: Q2 2026 in Review

Kozak & Associates reduced its Accenture (ACN) stake by 53% in Q2 2026, selling an estimated $21.2K and leaving 108 shares worth $14.2K. The position accounts for ﹤0.01% of the portfolio, ranked #234.

Kozak & Associates first reported a position in ACN in Q3 2021 and has held it in 20 quarters since. The position peaked at $117K in Q3 2021. 736 funds tracked by Wall St. Rank hold ACN as of Q2 2026.

  • Kozak & Associates held 108 shares of Accenture worth $14.2K as of Q2 2026.
  • Kozak & Associates sold 122 Accenture shares in Q2 2026, an estimated $21.2K.
  • Accenture made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #234 holding.
  • Kozak & Associates first reported a position in Accenture in Q3 2021 and has held it in 20 quarters since.
  • Kozak & Associates's Accenture position peaked at $117K in Q3 2021.
  • 736 funds tracked by Wall St. Rank held Accenture as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.